Clinical Trial Update: DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis [Phase 3]

View source ↗

Summary

Phase 3 DIVA study evaluating different intravenous regimens of ibandronate (Bonviva) for postmenopausal osteoporosis; the trial completed and posted results in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Bonviva (ibandronic acid)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Post Menopausal Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2016-02-03